The available treatments and FDAapproved vaccines for RSV only lessen the severity of the infection and are recommended for infants and elderly people. Methods: We focused on developing a broad-spectrum vaccine that activates the immune system to directly combat RSV. The ...
Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections in infants worldwide. Despite decades of research, there is still no registered vaccine available for this major pathogen. We investigated the protective efficacy of a recombinant influenza virus, PR8/NA-F...
50,000 infants.]]>Taranger J, Trollfors B, Bergfors E, Rönne T. Safety experience with a monocomponent acellular pertussis vaccine: no reported hypotonic-hyporesponsive episodes in >50,000 infants. 108 American Pediatric Society and 67 Society for Pedictric Research, New Orleans, USA, 1998...
Jun L,Yuguo C,Zhiguo W,et al.Assessment of immunogenicity and safety following primary and booster immunization with a CRM197-conjugate Haemophilus influenzae type B vaccine in healthy Chinese infants[J].Int J Clin Pract,2013,67(10):971-978....